166 related articles for article (PubMed ID: 35963552)
1. Impact of hereditary thrombophilia on cancer-associated thrombosis, tumour susceptibility and progression: A review of existing evidence.
Tavares V; Neto BV; Vilas-Boas MI; Pereira D; Medeiros R
Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188778. PubMed ID: 35963552
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated thrombosis: What about microRNAs targeting the tissue factor coagulation pathway?
Tavares V; Neto BV; Marques IS; Assis J; Pereira D; Medeiros R
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189053. PubMed ID: 38092078
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs as prognostic biomarkers for (cancer-associated) venous thromboembolism.
Anijs RJS; Nguyen YN; Cannegieter SC; Versteeg HH; Buijs JT
J Thromb Haemost; 2023 Jan; 21(1):7-17. PubMed ID: 36695398
[TBL] [Abstract][Full Text] [Related]
4. Impact of thrombophilic genes mutations on thrombosis risk in Egyptian nonmetastatic cancer patients.
Wahba MA; Ismail MA; Saad AA; Habashy DM; Hafeez ZM; Boshnak NH
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):309-15. PubMed ID: 25565385
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of different risk factor profiles in patients with mesenteric venous thrombosis and systemic venous thromboembolism: a population-based study.
Salim S; Zarrouk M; Elf J; Gottsäter A; Sveinsdottir S; Svensson P; Acosta S
J Thromb Thrombolysis; 2019 May; 47(4):572-577. PubMed ID: 30756343
[TBL] [Abstract][Full Text] [Related]
6. Factor V 1691 G-A (Leiden) polymorphism and cancer-related venous thromboembolism: a meta-analysis of published studies.
Eroglu A; Sertkaya Karasoy D; Eroglu N; Akar N
J BUON; 2008; 13(1):61-4. PubMed ID: 18404788
[TBL] [Abstract][Full Text] [Related]
7. Genetic Risk Factors in Venous Thromboembolism.
Hotoleanu C
Adv Exp Med Biol; 2017; 906():253-272. PubMed ID: 27638626
[TBL] [Abstract][Full Text] [Related]
8. Thrombophilia and venous thromboembolism: implications for testing.
Cohn DM; Roshani S; Middeldorp S
Semin Thromb Hemost; 2007 Sep; 33(6):573-81. PubMed ID: 17768689
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for symptomatic venous and arterial thromboembolism in newborns, children and adolescents - What did we learn within the last 20years?
Kenet G; Limperger V; Shneyder M; Nowak-Göttl U
Blood Cells Mol Dis; 2017 Sep; 67():18-22. PubMed ID: 28010922
[TBL] [Abstract][Full Text] [Related]
10. Thrombogenesis-associated genetic determinants as predictors of thromboembolism and prognosis in cervical cancer.
Neto BV; Tavares V; da Silva JB; Liz-Pimenta J; Marques IS; Carvalho L; Salgado L; Pereira D; Medeiros R
Sci Rep; 2023 Jun; 13(1):9519. PubMed ID: 37308506
[TBL] [Abstract][Full Text] [Related]
11. Venous Thromboembolism: Genetics and Thrombophilias.
Gaddh M; Rosovsky RP
Semin Respir Crit Care Med; 2021 Apr; 42(2):271-283. PubMed ID: 33694139
[TBL] [Abstract][Full Text] [Related]
12. The dos, don'ts, and nuances of thrombophilia testing.
Chiasakul T; Bauer KA
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):593-599. PubMed ID: 38066917
[TBL] [Abstract][Full Text] [Related]
13. Changes in Biomarkers of Coagulation, Fibrinolytic, and Endothelial Functions for Evaluating the Predisposition to Venous Thromboembolism in Patients With Hereditary Thrombophilia.
Li L; Gao L; Wu X; Wu W; Ding Q; Wang X
Clin Appl Thromb Hemost; 2020; 26():1076029620944471. PubMed ID: 32886527
[TBL] [Abstract][Full Text] [Related]
14. Acquired Thrombophilia.
Armstrong EM; Bellone JM; Hornsby LB; Treadway S; Phillippe HM
J Pharm Pract; 2014 Jun; 27(3):234-42. PubMed ID: 24742931
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism GWAS reported genetic makeup and the hallmarks of cancer: Linkage to ovarian tumour behaviour.
Tavares V; Pinto R; Assis J; Pereira D; Medeiros R
Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188331. PubMed ID: 31689458
[TBL] [Abstract][Full Text] [Related]
16. Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients.
Ay C; Pabinger I
Thromb Res; 2012 Apr; 129 Suppl 1():S6-9. PubMed ID: 22682135
[TBL] [Abstract][Full Text] [Related]
17. Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium.
Gerhardt A; Scharf RE; Greer IA; Zotz RB
Blood; 2016 Nov; 128(19):2343-2349. PubMed ID: 27613196
[TBL] [Abstract][Full Text] [Related]
18. Cancer prognosis in patients with venous thromboembolism (VTE) and patients with clinical and laboratory biomarkers predictive of VTE risk.
Liebman HA
Thromb Res; 2018 Apr; 164 Suppl 1():S19-S22. PubMed ID: 29703479
[TBL] [Abstract][Full Text] [Related]
19. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in patients with unprovoked VTE.
Robertson L; Yeoh SE; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2015 Mar; (3):CD010837. PubMed ID: 25749503
[TBL] [Abstract][Full Text] [Related]
20. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Yeoh SE; Broderick C; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD010837. PubMed ID: 30407621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
